not tagged
oncxerna therapeutics
['biomarker', 'gastric', 'oncxerna', 'marker ']
#oncxernatherapeutics announces new #xernatme panel #biomarker data from retrospective analysis of results from a randomized phase 2 trial evaluating #antipd1 #maintenancetherapy in #esophagogastricadenocarcinoma at the #esmo22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.